Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

2.

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE.

Cancer Res. 2000 Sep 15;60(18):5117-24.

3.
4.

Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.

Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, Black SM.

Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L222-31. Epub 2003 Mar 28.

5.

Vascular endothelial growth factor as a marker of tumor endothelium.

Brekken RA, Huang X, King SW, Thorpe PE.

Cancer Res. 1998 May 1;58(9):1952-9.

6.

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.

Hepatology. 1999 Nov;30(5):1179-86.

PMID:
10534339
7.

Vascular endothelial growth factor and vascular targeting of solid tumors.

Brekken RA, Thorpe PE.

Anticancer Res. 2001 Nov-Dec;21(6B):4221-9. Review.

PMID:
11908675
8.

Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.

McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W.

J Pediatr Surg. 2003 Mar;38(3):308-14; discussion 308-14.

PMID:
12632340
9.
10.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
11.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
12.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

14.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
15.

VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.

Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY.

Surgery. 2002 Dec;132(6):1056-63; discussion 1063.

PMID:
12490855
16.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Brekken RA, Thorpe PE.

J Control Release. 2001 Jul 6;74(1-3):173-81. Review.

PMID:
11489493
17.

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA.

Mol Cancer Ther. 2009 Jul;8(7):1761-71. doi: 10.1158/1535-7163.MCT-09-0280. Epub 2009 Jun 30.

18.

Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.

Kojima-Yuasa A, Hua JJ, Kennedy DO, Matsui-Yuasa I.

Life Sci. 2003 Jul 25;73(10):1299-313.

PMID:
12850245
20.

Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.

Nakopoulou L, Stefanaki K, Panayotopoulou E, Giannopoulou I, Athanassiadou P, Gakiopoulou-Givalou H, Louvrou A.

Hum Pathol. 2002 Sep;33(9):863-70.

PMID:
12378509

Supplemental Content

Support Center